Tmj Treatment denied as non-formulary by Cigna?

Cigna's specific coverage criteria for tmj treatment are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denies TMJ Treatment as Non-Formulary — and How to Appeal

A non-formulary denial from Cigna for TMJ treatment means the specific medication, device, or product prescribed is not included on your plan's covered product list. This is an administrative classification, not a clinical judgment — and it can be challenged through a formulary exception or a formal appeal.

## Why This Denial Happens

Cigna's formulary covers specific drugs and, in some plans, specific devices or products. TMJ treatment may involve prescription medications, custom oral appliances, or other items that vary in their formulary status across plans. Your specific plan may have a formulary that excludes the prescribed item. The denial does not reflect a determination that the treatment is medically inappropriate — only that it wasn't on the approved list. Formulary exceptions exist precisely for situations where no covered alternative is clinically appropriate.

## Your Federal Appeal Rights

• ACA Section 2719: Provides the right to internal appeal and independent external review. External review requests are generally due within approximately four months of the denial — confirm the exact deadline on your EOB.
• ERISA Section 503: Employer-plan members have full-and-fair review rights with written denial reasons.
• Formulary exception process: This is often faster than a full appeal. Your prescriber can formally request that Cigna approve coverage of the non-formulary item based on medical necessity — particularly if no covered formulary alternative is clinically appropriate for your condition.
• Expedited review: Available when delay poses a health risk.

## The Concrete Appeal Process

1. Request the formulary exception first. Your prescriber submits a letter documenting why the non-formulary item is medically necessary and why covered alternatives are not clinically appropriate for you specifically. 2. If the exception is denied, file a formal internal appeal with complete clinical documentation. 3. Request external review if the internal appeal is upheld. 4. Check whether the formulary has changed. Formularies are updated periodically — in some cases the item may have been added or removed since the denial.

## Documentation to Gather

• Diagnosis confirmation: Clinical notes confirming the specific TMJ diagnosis, severity, and clinical course.
• Formulary alternative review: Documentation that covered formulary alternatives were considered and, where applicable, tried — with dates, outcomes, and clinical reasons they are inadequate or inappropriate for this patient.
• Prescriber exception letter: Explains why the specific non-formulary product is medically necessary, what alternatives were considered, and the clinical basis for selecting the non-formulary item.
• Product documentation: If a device or appliance is involved, documentation of the product's FDA clearance or approval and any product-specific clinical evidence relevant to your condition.

## Criteria-Mapping Structure

Create a side-by-side table:

| Cigna's Formulary Exception or Appeal Requirement | Your Supporting Evidence | |---|---| | Copy each stated requirement from Cigna's exception policy or denial letter | Enter the chart note, prescriber statement, or clinical record that satisfies it |

Obtain Cigna's current formulary and exception criteria directly from Cigna — these documents change and your appeal must address the current version. Formulary exception requests with a strong prescriber letter addressing covered alternatives are resolved favorably more often than they reach formal external review.